首页|期刊导航|眼科学报|1990-2021年中国儿童群体中视网膜母细胞瘤疾病负担变化趋势分析

1990-2021年中国儿童群体中视网膜母细胞瘤疾病负担变化趋势分析OA

The disease burden of retinoblastoma among Chinese children and its temporal trends,1990-2021

中文摘要英文摘要

目的:分析中国 1990-2021 年 5 岁以下儿童视网膜母细胞瘤(retinoblastoma,RB)的疾病负担及变化趋势,为国家公共卫生策略制定提供依据.方法:采集全球疾病负担(global burden of disease,GBD)研究中国 5 岁以下儿童 1990-2021 年的 RB 数据,采用发病率、死亡率及伤残调整寿命年(disability-adjusted life years,DALYs)率指标分析疾病负担;通过 Joinpoint 回归分析评估 RB 疾病负担变化趋势,并计算年度变化百分比(annual percent change,APC)与平均年度变化百分比(average annual percent change,AAPC);通过分层分析,评估不同性别和年龄的疾病负担差异;使用 Spearman 秩相关分析与局部加权回归方法探究疾病负担与社会人口指数(socio-demographic index,SDI)之间的相关性.结果:1990-2021 年中国 RB 年龄标准化发病率(age-standardized incidence rate,ASIR)总体呈上升趋势(AAPC=2.87),尤其在 2019 年前增长显著,但 2019 年后出现下降;2021 年中国 ASIR 达 1.23(95%UI:0.47~1.96);而年龄标准化死亡率(age-standardized mortality rate,ASMR)和年龄标准化 DALY 率(age-standardized DALY rate,ASDR)则持续下降(AAPC 分别为-4.02 和-3.72).女性 RB 负担高于男性,2~4岁儿童是疾病负担的主要群体.此外,RB 发病率与SDI 呈正相关,死亡率及DALYs 与SDI 呈负相关,提示社会经济因素显著影响 RB 负担.结论:中国 RB 发病率的上升可能与早期诊断技术进步有关,而死亡率下降则得益于治疗手段的改进.然而,地区间医疗资源分配不均仍是未来疾病防控与诊治中的重点问题.加强基层医疗能力建设,推广人工智能辅助诊断,以实现更公平、更高效的 RB 防治.

Objective:To analyze the disease burden and trends of retinoblastoma(RB)among children under 5 years of age in China from 1990 to 2021,and to provide evidence to inform public health strategies.Methods:Data on RB in Chinese children under 5 years of age from 1990 to 2021 were extracted from the Global Burden of Disease(GBD)study The disease burden was evaluated using incidence,mortality,and disability-adjusted life year(DALY)rates.Joinpoint regression was used to assess temporal trends by calculating the annual percentage change(APC)and average annual percentage change(AAPC).Stratified analyses were conducted to evaluate differences by sex and age.Spearman's rank correlation and locally weighted regression were applied to explore the association between the disease burden and the Socio-demographic Index(SDI).Results:Between 1990 and 2021,the age-standardized incidence rate(ASIR)of RB in China showed an overall increasing trend(AAPC,2.87%),rising significantly before 2019 and declining thereafter,reaching 1.23(95%UI:0.47-1.96)per 100,000 in 2021.In contrast,the age-standardized mortality rate(ASMR)and age-standardized DALY rate(ASDR)decreased consistently(AAPC:-4.02 and-3.72,respectively).The RB burden was higher in females than in males,and children aged 2-4 years accounted for the majority of the burden.Furthermore,the ASIR was positively correlated with the SDI,whereas the ASMR and ASDR were negatively correlated with SDI,indicating a significant impact of socioeconomic development on the RB burden.Conclusions:The rising incidence of RB in China may be associated with improvements in early diagnosis,while the decline in mortality likely reflects advancements in treatment.However,regional disparities in medical resource allocation remain a major challenge for future RB management.Strengthening primary healthcare capacity and promoting AI-assisted diagnosis are essential for achieving more equitable and efficient RB care.

李雯斐;司鸿宇;周慧璇;杨伟敏;肖伟

中山大学中山眼科中心,眼病防治全国重点实验室,广东省眼科视觉科学重点实验室,广州 510060中山大学中山眼科中心,眼病防治全国重点实验室,广东省眼科视觉科学重点实验室,广州 510060中山大学中山眼科中心,眼病防治全国重点实验室,广东省眼科视觉科学重点实验室,广州 510060中山大学中山眼科中心,眼病防治全国重点实验室,广东省眼科视觉科学重点实验室,广州 510060中山大学中山眼科中心,眼病防治全国重点实验室,广东省眼科视觉科学重点实验室,广州 510060

医药卫生

视网膜母细胞瘤疾病负担发病率死亡率伤残调整寿命年

retinoblastomaglobal burden of diseaseincidencemortalitydisability-adjusted life year

《眼科学报》 2026 (8)

623-633,11

广东省基础与应用基础研究基金(2023A1515012192).This work was supported by the Guangdong Basic and Applied Basic Research Foundation(2023A1515012192).

10.12419/25112904

评论